Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $GTHP vs $IRIX | Chartloom

Compare

$GTHP vs $IRIX

Guided Therapeutics Inc · IRIDEX Corp

GTHP

Guided Therapeutics Inc

IRIX

IRIDEX Corp

Compare $GTHP vs $IRIX

Comparing Guided Therapeutics Inc and IRIDEX Corp

GTHPGuided Therapeutics Inc

IRIXIRIDEX Corp

GTHPGuided Therapeutics Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-64.8%

52W performance

-17.4%

FCF yield

-8.2%

IRIXIRIDEX Corp

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

3.7%

YTD performance

-27.5%

52W performance

-18.4%

FCF yield

-13.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTHP

IRIX

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

IRIX

IRIDEX Corp

Market Cap

GTHP$18M

IRIX$15M

Enterprise Value

GTHP$20M

IRIX$14M

Price

GTHP$0.19

IRIX$0.85

P/E Ratio

GTHPN/A

IRIXN/A

P/S Ratio

GTHP28.22x

IRIX0.29x

EV/Sales

GTHP31.44x

IRIX0.27x

EV/EBITDA

GTHP0.00x

IRIX15.52x

P/B Ratio

GTHP35.27x

IRIX4.30x

P/FCF Ratio

GTHPN/A

IRIXN/A

EV/FCF

GTHP-13.57x

IRIX-6.94x

PEG Ratio

GTHPN/A

IRIXN/A

Forward P/E (NTM)

GTHPN/A

IRIXN/A

Forward P/S (NTM)

GTHPN/A

IRIXN/A

Revenue (TTM)

GTHP$650K

IRIX$52M

Revenue Growth (YoY)

GTHP450.8%

IRIX3.7%

Forward Rev Growth

GTHP0.0%

IRIX6.6%

Gross Margin (TTM)

GTHP75.8%

IRIX35.9%

Operating Margin (TTM)

GTHP0.0%

IRIX0.0%

EBITDA Margin (TTM)

GTHP-336.2%

IRIX-4.5%

Net Margin (TTM)

GTHP-560.6%

IRIX-6.9%

FCF Margin (TTM)

GTHP-231.7%

IRIX-3.9%

Net Income (TTM)

GTHP$-4M

IRIX$-4M

FCF (TTM)

GTHP$-2M

IRIX$-2M

EPS (TTM)

GTHP-$0.04

IRIX-$0.20

ROE (TTM)

GTHP-47148.0%

IRIX-7894.0%

ROA (TTM)

GTHP-24393.0%

IRIX-1255.0%

ROIC (TTM)

GTHP-37126.0%

IRIX-4303.0%

Cash

GTHP$12K

IRIX$5M

Debt

GTHP$2M

IRIX$4M

Net Cash/Debt

GTHP$-2M

IRIX$885K

Current Ratio (TTM)

GTHP0.09x

IRIX1.82x

Quick Ratio (TTM)

GTHP0.00x

IRIX0.89x

Debt/Equity (TTM)

GTHP0.60x

IRIX1.04x

Debt/Assets (TTM)

GTHP0.0%

IRIX0.0%

Interest Coverage (TTM)

GTHPN/A

IRIXN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

IRIX0.00x

Beta

GTHP0.68

IRIX0.69

52W Performance

GTHP-17.4%

IRIX-18.4%

YTD Performance

GTHP-64.8%

IRIX-27.5%

% from 52W High

GTHP-64.8%

IRIX-48.5%

% from 52W Low

GTHP58.3%

IRIX39.8%

Asset Turnover (TTM)

GTHP0.73x

IRIX1.83x

FCF Yield (TTM)

GTHP-8.2%

IRIX-13.5%

Earnings Yield (TTM)

GTHP-19.9%

IRIX-24.0%

Dividend Yield (TTM)

GTHPN/A

IRIXN/A

Rule of 40

GTHP219.2

IRIX-0.2

EV/GP/RG

GTHPN/A

IRIX0.11

Ticker research

View GTHP research View IRIX research

Metric	GTHP Guided Therapeutics Inc	IRIX IRIDEX Corp
Market & Valuation
Market Cap	$18M	$15M
Enterprise Value	$20M	$14M
Price	$0.19	$0.85
P/E Ratio	N/A	N/A
P/S Ratio	28.22x	0.29x
EV/Sales	31.44x	0.27x
EV/EBITDA	0.00x	15.52x
P/B Ratio	35.27x	4.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.57x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$650K	$52M
Revenue Growth (YoY)	450.8%	3.7%
Forward Rev Growth	0.0%	6.6%
Profitability
Gross Margin (TTM)	75.8%	35.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-4.5%
Net Margin (TTM)	-560.6%	-6.9%
FCF Margin (TTM)	-231.7%	-3.9%
Net Income (TTM)	$-4M	$-4M
FCF (TTM)	$-2M	$-2M
EPS (TTM)	-$0.04	-$0.20
ROE (TTM)	-47148.0%	-7894.0%
ROA (TTM)	-24393.0%	-1255.0%
ROIC (TTM)	-37126.0%	-4303.0%
Financial Health
Cash	$12K	$5M
Debt	$2M	$4M
Net Cash/Debt	$-2M	$885K
Current Ratio (TTM)	0.09x	1.82x
Quick Ratio (TTM)	0.00x	0.89x
Debt/Equity (TTM)	0.60x	1.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	0.69
52W Performance	-17.4%	-18.4%
YTD Performance	-64.8%	-27.5%
% from 52W High	-64.8%	-48.5%
% from 52W Low	58.3%	39.8%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	1.83x
FCF Yield (TTM)	-8.2%	-13.5%
Earnings Yield (TTM)	-19.9%	-24.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-0.2
EV/GP/RG	N/A	0.11
Ticker research	View GTHP research	View IRIX research

Valuation

P/S Ratio

IRIX

0.29x

GTHP

28.22x

EV/FCF

GTHP

-13.57x

IRIX

-6.94x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

IRIX

3.7%

Forward Revenue Growth

IRIX

6.6%

GTHP

0.0%

Profitability & performance

Gross Margin

GTHP

75.8%

IRIX

35.9%

ROE

IRIX

-7894.0%

GTHP

-47148.0%

FCF Yield %

GTHP

-8.2%

IRIX

-13.5%

52-Week Performance

GTHP

-17.4%

IRIX

-18.4%

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

IRIX

IRIDEX Corp

Market Cap

GTHP$18M

IRIX$15M

Enterprise Value

GTHP$20M

IRIX$14M

Price

GTHP$0.19

IRIX$0.85

P/E Ratio

GTHPN/A

IRIXN/A

P/S Ratio

GTHP28.22x

IRIX0.29x

EV/Sales

GTHP31.44x

IRIX0.27x

EV/EBITDA

GTHP0.00x

IRIX15.52x

P/B Ratio

GTHP35.27x

IRIX4.30x

P/FCF Ratio

GTHPN/A

IRIXN/A

EV/FCF

GTHP-13.57x

IRIX-6.94x

PEG Ratio

GTHPN/A

IRIXN/A

Forward P/E (NTM)

GTHPN/A

IRIXN/A

Forward P/S (NTM)

GTHPN/A

IRIXN/A

Revenue (TTM)

GTHP$650K

IRIX$52M

Revenue Growth (YoY)

GTHP450.8%

IRIX3.7%

Forward Rev Growth

GTHP0.0%

IRIX6.6%

Gross Margin (TTM)

GTHP75.8%

IRIX35.9%

Operating Margin (TTM)

GTHP0.0%

IRIX0.0%

EBITDA Margin (TTM)

GTHP-336.2%

IRIX-4.5%

Net Margin (TTM)

GTHP-560.6%

IRIX-6.9%

FCF Margin (TTM)

GTHP-231.7%

IRIX-3.9%

Net Income (TTM)

GTHP$-4M

IRIX$-4M

FCF (TTM)

GTHP$-2M

IRIX$-2M

EPS (TTM)

GTHP-$0.04

IRIX-$0.20

ROE (TTM)

GTHP-47148.0%

IRIX-7894.0%

ROA (TTM)

GTHP-24393.0%

IRIX-1255.0%

ROIC (TTM)

GTHP-37126.0%

IRIX-4303.0%

Cash

GTHP$12K

IRIX$5M

Debt

GTHP$2M

IRIX$4M

Net Cash/Debt

GTHP$-2M

IRIX$885K

Current Ratio (TTM)

GTHP0.09x

IRIX1.82x

Quick Ratio (TTM)

GTHP0.00x

IRIX0.89x

Debt/Equity (TTM)

GTHP0.60x

IRIX1.04x

Debt/Assets (TTM)

GTHP0.0%

IRIX0.0%

Interest Coverage (TTM)

GTHPN/A

IRIXN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

IRIX0.00x

Beta

GTHP0.68

IRIX0.69

52W Performance

GTHP-17.4%

IRIX-18.4%

YTD Performance

GTHP-64.8%

IRIX-27.5%

% from 52W High

GTHP-64.8%

IRIX-48.5%

% from 52W Low

GTHP58.3%

IRIX39.8%

Asset Turnover (TTM)

GTHP0.73x

IRIX1.83x

FCF Yield (TTM)

GTHP-8.2%

IRIX-13.5%

Earnings Yield (TTM)

GTHP-19.9%

IRIX-24.0%

Dividend Yield (TTM)

GTHPN/A

IRIXN/A

Rule of 40

GTHP219.2

IRIX-0.2

EV/GP/RG

GTHPN/A

IRIX0.11

Ticker research

View GTHP research View IRIX research

Metric	GTHP Guided Therapeutics Inc	IRIX IRIDEX Corp
Market & Valuation
Market Cap	$18M	$15M
Enterprise Value	$20M	$14M
Price	$0.19	$0.85
P/E Ratio	N/A	N/A
P/S Ratio	28.22x	0.29x
EV/Sales	31.44x	0.27x
EV/EBITDA	0.00x	15.52x
P/B Ratio	35.27x	4.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.57x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$650K	$52M
Revenue Growth (YoY)	450.8%	3.7%
Forward Rev Growth	0.0%	6.6%
Profitability
Gross Margin (TTM)	75.8%	35.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-4.5%
Net Margin (TTM)	-560.6%	-6.9%
FCF Margin (TTM)	-231.7%	-3.9%
Net Income (TTM)	$-4M	$-4M
FCF (TTM)	$-2M	$-2M
EPS (TTM)	-$0.04	-$0.20
ROE (TTM)	-47148.0%	-7894.0%
ROA (TTM)	-24393.0%	-1255.0%
ROIC (TTM)	-37126.0%	-4303.0%
Financial Health
Cash	$12K	$5M
Debt	$2M	$4M
Net Cash/Debt	$-2M	$885K
Current Ratio (TTM)	0.09x	1.82x
Quick Ratio (TTM)	0.00x	0.89x
Debt/Equity (TTM)	0.60x	1.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	0.69
52W Performance	-17.4%	-18.4%
YTD Performance	-64.8%	-27.5%
% from 52W High	-64.8%	-48.5%
% from 52W Low	58.3%	39.8%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	1.83x
FCF Yield (TTM)	-8.2%	-13.5%
Earnings Yield (TTM)	-19.9%	-24.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-0.2
EV/GP/RG	N/A	0.11
Ticker research	View GTHP research	View IRIX research